Skip to Content

Newcardio Inc NWCI

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Newcardio Inc. focuses on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease, as well as the cardiac safety assessment of new drugs under development.

Contact
PO Box 658, Neshanic
Somerset, NJ, 08853
T +1 408 516-5000
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Sep 30, 2011
Fiscal Year End Dec 31, 2011
Stock Type Distressed
Employees 11